Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Urology, Nephrology and Andrology International

Volume  3, Issue 2, Jul-Dec 2018, Pages 35-40
 

Original Article

Clinical Profile and Patient Outcomes of Crescentic Glomerulonephritis: A Descriptive Study in a Tertiary Care Hospital

Prashant G Kedlaya1, Nithin J2, Renuka Satish3, Limesh M4

1Professor 2Assistant Professor 3Professor and Head 4Associate Professor, Department of Nephrology, St. John’s Medical College, Bangalore, Karnataka 560034, India

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/unai.2456-5016.3218.2

Abstract

Background: Crescentic glomerulonephritis (CSGN) requires early intervention which can make a significant impact on minimizing irreversible kidney damage and improving patient outcomes Data regarding the clinical and histopathologic spectrum of CSGN among the Indian adult population is sparse. Objective: To study the etiology, clinicopathological features, prognostic factors and outcome of CSGN in Indian population. Method: This prospective, descriptive study was carried out in the Department of Nephrology, St John’s Medical College Hospital, Bengaluru which is a large territory care hospital in South India from July 2015 to October 2017. 37 patients diagnosed as CSGN on renal biopsy were studied. Results: The mean age of presentation in our study was 38.8 ± 13.7 years. The most common clinical presentation was in the form of rapidly progressive renal failure (54.1%). The most common etiological diagnosis was immune complex mediated glomerulonephritis (64.8%), followed second by pauci-immune GN (27%). Among immune complex group, IgA nephropathy was the leading cause (32.4%) and had the worst prognosis. The serum creatinine at presentation was an important prognostic marker with value of more than 5 mg/dl having poor outcome with 75% reaching end stage renal disease. Almost half of patients (50%) requiring renal replacement therapy at presentation reached end stage renal disease (ESRD). Conclusion: Crescentic GNs most commonly seen between third to fifth decades of life. Immune-complex glomerulonephritis (IgA nephropathy being the predominant disease) is the most common etiology of CSGN followed by anti-neutrophil cytoplasmic antibody positive pauci-immune GN. The predominant factors influencing renal outcomes were the extent of renal failure at presentation, need for renal replacement therapy at presentation and renal histology. Early diagnosis and therapy may facilitate favourable renal and patient outcomes. 

Keywords: RPGN; Crescentic glomerulonephritis; South India.   


Corresponding Author : Nithin J., Assistant Professor, Department of Nephrology, St. John’s Medical College, Bangalore, Karnataka 560034, India.